First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised …
EP Navarese, M Kowalewski, D Kandzari, A Lansky… - Open …, 2014 - openheart.bmj.com
Background First-generation drug-eluting stents (DES) have become the most widely used
devices worldwide for management of coronary artery disease. As remote follow-up data …
devices worldwide for management of coronary artery disease. As remote follow-up data …
The relationship between re‐endothelialization and endothelial function after DES implantation: Comparison between paclitaxcel eluting stent and zotarolims eluting …
S Murase, Y Suzuki, T Yamaguchi… - Catheterization and …, 2014 - Wiley Online Library
Background Several studies have reported re‐endothelialization and endothelial function
after drug‐eluting stent (DES) implantation; however, the relationship between re …
after drug‐eluting stent (DES) implantation; however, the relationship between re …
[HTML][HTML] Long-term (2–5 years) adverse clinical outcomes associated with ZES versus SES, PES and EES: A Meta-Analysis
PK Bundhun, A Bhurtu, M Pursun, MZS Soogund… - Scientific reports, 2017 - nature.com
Several previously published trials comparing Zotarolimus Eluting Stents (ZES) with
Sirolimus Eluting Stents (SES), Paclitaxel Eluting Stents (PES) or Everolimus Eluting Stents …
Sirolimus Eluting Stents (SES), Paclitaxel Eluting Stents (PES) or Everolimus Eluting Stents …
Fabrication and evaluation of polyelectrolyte complexes of dextran derivatives for drug coating of coronary stents
EJ Jang, SY Lee, IH Bae, DS Park… - Applied Chemistry for …, 2019 - koreascience.kr
The aim of this study was to fabricate a dextran polyelectrolyte multi-layer on a bare metal
stent (BMS) and to evaluate bio-physical properties of the layer. Diethylaminoethyl-dextran …
stent (BMS) and to evaluate bio-physical properties of the layer. Diethylaminoethyl-dextran …
[HTML][HTML] Impacto do uso rotineiro de stents farmacológicos na prática intervencionista contemporânea de um centro terciário: experiência de uma década do Registro …
JR Costa Jr, AGMR Sousa, AC Moreira… - Revista Brasileira de …, 2012 - SciELO Brasil
INTRODUÇÃO: Os stents farmacológicos (SFs) modificaram a prática intervencionista
contemporânea, permitindo abordar cenários clínicos e angiográficos progressivamente …
contemporânea, permitindo abordar cenários clínicos e angiográficos progressivamente …
[图书][B] Should network meta-analysis become the standard in evidence-based clinical practice?
R Brignardello-Petersen - 2016 - search.proquest.com
Network Meta-analysis (NMA) is a statistical tool that allows comparing and estimating the
relative effects of multiple interventions at the same time. Although its popularity has …
relative effects of multiple interventions at the same time. Although its popularity has …
[PDF][PDF] Randomisierter Vergleich eines Polymer-freien, Sirolimus-freisetzenden Stents mit einem Polymer-basierten, Paclitaxel-freisetzenden Stent bei Patienten mit …
A Heinz - zhb.uni-luebeck.de
Randomisierter Vergleich eines Polymer-freien, Sirolimus- freisetzenden Stents mit einem
Polymer-basierten, Paclitaxel-freisetze Page 1 1 Aus der Medizinischen Klinik II der Universität …
Polymer-basierten, Paclitaxel-freisetze Page 1 1 Aus der Medizinischen Klinik II der Universität …
[HTML][HTML] Двенадцатимесячные результаты ЧКВ с использованием сиролимус и эверолимус покрытых стентов
РС Поляков, СА Абугов, ГВ Марданян… - …, 2013 - cyberleninka.ru
Несмотря на кардинальное улучшение результатов ЧКВ с использованием СЛП, за-
медленная эндотелизация при имплантации СЛП увеличивает срок, в течение …
медленная эндотелизация при имплантации СЛП увеличивает срок, в течение …
[图书][B] Fabrication, biocompatibility, and tissue engineering substrate analysis of polyvinyl alcohol-gelatin core-shell electrospun nanofibers
VM Merkle - 2013 - search.proquest.com
Cardiovascular disease is the leading cause of death in the United States with
approximately 49% of the cardiovascular related deaths attributed to coronary heart disease …
approximately 49% of the cardiovascular related deaths attributed to coronary heart disease …